Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

New compounds show promise as nonsteroidal treatments for hair loss.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Finasteride, when given in high oral doses to pregnant monkeys, caused genital abnormalities in male fetuses, but not in female fetuses or those exposed to intravenous finasteride.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Finasteride may increase depression by reducing brain cell growth.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.